Cosmos Health forecasts $15 million U.S. sales

Full story: https://grafa.com/en/news/united-states/cosmos-health-q4-2026-us-revenue-15-million-forecast

Cosmos Health expects approximately $15 million in U.S. direct-to-consumer revenue for Q4 2026, supported by expanded marketing activity and subscription sales.
The company forecasts approximately $10.5 million in gross profit, equivalent to a 70% gross margin, for its U.S. online business.
Active U.S. subscriptions reportedly reached 8,940 on October 19, up 42% from October 14, with management targeting more than 40,000 by year-end.

Cosmos Health (NASDAQ:COSM) forecasts approximately $15 million in fourth-quarter 2026 U.S. direct-to-consumer revenue, with projected gross profit of $10.5 million.

The forecast represents a 70% gross margin for its U.S. online business, compared with roughly 8% company-wide GAAP gross margin in Q2.

Cosmos expects $8.2 million from new subscribers' first orders, $3.3 million from subscription renewals and $3.5 million from one-time purchases.

Active U.S. subscriptions reportedly increased 42% to 8,940 by October 19, compared with 6,287 five days earlier.

The company targets more than 40,000 active U.S. subscriptions and daily sales exceeding $200,000 by year-end, although neither outcome is guaranteed.

Cosmos previously reported preliminary nine-month revenue of $54.3 million and reaffirmed its forecast for full-year revenue exceeding $90 million.

The healthcare company operates pharmaceutical manufacturing and distribution businesses alongside proprietary nutraceutical brands, including Sky Premium Life and Mediterranation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":620315700699432,"tweetId":"620315700699432","gmtCreate":1792474972192,"gmtModify":1792474979545,"author":{"id":4169784042383112,"idStr":"4169784042383112","authorId":4169784042383112,"authorIdStr":"4169784042383112","name":"Grafa","avatar":"https://community-static.tradeup.com/news/ec1614006170d0aa3182195a94e8944d","vip":2,"userType":2,"introduction":"Grafa generates AI-driven data, news and analysis about NYSE, Nasdaq and ASX stocks","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":256,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/ca08f932a7d1e712b101e181c28330f6","width":"2688","height":"1520"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/ca08f932a7d1e712b101e181c28330f6","width":"2688","height":"1520"}],"title":"Cosmos Health forecasts $15 million U.S. sales","html":"<html><head></head><body><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/ca08f932a7d1e712b101e181c28330f6\" tg-width=\"2688\" tg-height=\"1520\"></p>\n<p>Full story: https://grafa.com/en/news/united-states/cosmos-health-q4-2026-us-revenue-15-million-forecast</p>\n<ul>\n <li>\n  <p>Cosmos Health expects approximately $15 million in U.S. direct-to-consumer revenue for Q4 2026, supported by expanded marketing activity and subscription sales.</p></li>\n <li>\n  <p>The company forecasts approximately $10.5 million in gross profit, equivalent to a 70% gross margin, for its U.S. online business.</p></li>\n <li>\n  <p>Active U.S. subscriptions reportedly reached 8,940 on October 19, up 42% from October 14, with management targeting more than 40,000 by year-end.</p></li>\n</ul>\n<p style=\"text-align: start;\">Cosmos Health (NASDAQ:COSM) forecasts approximately $15 million in fourth-quarter 2026 U.S. direct-to-consumer revenue, with projected gross profit of $10.5 million.</p>\n<p style=\"text-align: start;\">The forecast represents a 70% gross margin for its U.S. online business, compared with roughly 8% company-wide GAAP gross margin in Q2.</p>\n<p style=\"text-align: start;\">Cosmos expects $8.2 million from new subscribers' first orders, $3.3 million from subscription renewals and $3.5 million from one-time purchases.</p>\n<p style=\"text-align: start;\">Active U.S. subscriptions reportedly increased 42% to 8,940 by October 19, compared with 6,287 five days earlier.</p>\n<p style=\"text-align: start;\">The company targets more than 40,000 active U.S. subscriptions and daily sales exceeding $200,000 by year-end, although neither outcome is guaranteed.</p>\n<p style=\"text-align: start;\">Cosmos previously reported preliminary nine-month revenue of $54.3 million and reaffirmed its forecast for full-year revenue exceeding $90 million.</p>\n<p style=\"text-align: start;\">The healthcare company operates pharmaceutical manufacturing and distribution businesses alongside proprietary nutraceutical brands, including Sky Premium Life and Mediterranation.</p></body></html>","htmlText":"<html><head></head><body><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/ca08f932a7d1e712b101e181c28330f6\" tg-width=\"2688\" tg-height=\"1520\"></p>\n<p>Full story: https://grafa.com/en/news/united-states/cosmos-health-q4-2026-us-revenue-15-million-forecast</p>\n<ul>\n <li>\n  <p>Cosmos Health expects approximately $15 million in U.S. direct-to-consumer revenue for Q4 2026, supported by expanded marketing activity and subscription sales.</p></li>\n <li>\n  <p>The company forecasts approximately $10.5 million in gross profit, equivalent to a 70% gross margin, for its U.S. online business.</p></li>\n <li>\n  <p>Active U.S. subscriptions reportedly reached 8,940 on October 19, up 42% from October 14, with management targeting more than 40,000 by year-end.</p></li>\n</ul>\n<p style=\"text-align: start;\">Cosmos Health (NASDAQ:COSM) forecasts approximately $15 million in fourth-quarter 2026 U.S. direct-to-consumer revenue, with projected gross profit of $10.5 million.</p>\n<p style=\"text-align: start;\">The forecast represents a 70% gross margin for its U.S. online business, compared with roughly 8% company-wide GAAP gross margin in Q2.</p>\n<p style=\"text-align: start;\">Cosmos expects $8.2 million from new subscribers' first orders, $3.3 million from subscription renewals and $3.5 million from one-time purchases.</p>\n<p style=\"text-align: start;\">Active U.S. subscriptions reportedly increased 42% to 8,940 by October 19, compared with 6,287 five days earlier.</p>\n<p style=\"text-align: start;\">The company targets more than 40,000 active U.S. subscriptions and daily sales exceeding $200,000 by year-end, although neither outcome is guaranteed.</p>\n<p style=\"text-align: start;\">Cosmos previously reported preliminary nine-month revenue of $54.3 million and reaffirmed its forecast for full-year revenue exceeding $90 million.</p>\n<p style=\"text-align: start;\">The healthcare company operates pharmaceutical manufacturing and distribution businesses alongside proprietary nutraceutical brands, including Sky Premium Life and Mediterranation.</p></body></html>","text":"Full story: https://grafa.com/en/news/united-states/cosmos-health-q4-2026-us-revenue-15-million-forecast Cosmos Health expects approximately $15 million in U.S. direct-to-consumer revenue for Q4 2026, supported by expanded marketing activity and subscription sales. The company forecasts approximately $10.5 million in gross profit, equivalent to a 70% gross margin, for its U.S. online business. Active U.S. subscriptions reportedly reached 8,940 on October 19, up 42% from October 14, with management targeting more than 40,000 by year-end. Cosmos Health (NASDAQ:COSM) forecasts approximately $15 million in fourth-quarter 2026 U.S. direct-to-consumer revenue, with projected gross profit of $10.5 million. The forecast represents a 70% gross margin for its U.S. online business, compared with roughly 8% company-wide GAAP gross margin in Q2. Cosmos expects $8.2 million from new subscribers' first orders, $3.3 million from subscription renewals and $3.5 million from one-time purchases. Active U.S. subscriptions reportedly increased 42% to 8,940 by October 19, compared with 6,287 five days earlier. The company targets more than 40,000 active U.S. subscriptions and daily sales exceeding $200,000 by year-end, although neither outcome is guaranteed. Cosmos previously reported preliminary nine-month revenue of $54.3 million and reaffirmed its forecast for full-year revenue exceeding $90 million. The healthcare company operates pharmaceutical manufacturing and distribution businesses alongside proprietary nutraceutical brands, including Sky Premium Life and Mediterranation.","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/620315700699432","repostId":0,"isVote":1,"tweetType":1,"viewCount":0,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1381,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/620315700699432"}